Satellos Bioscience Inc.
MSLE
$6.38
$0.304.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.73% | -42.92% | 99.65% | 88.84% | 68.15% |
| Total Receivables | 114.79% | -14.94% | 44.98% | -74.65% | -48.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -73.03% | 3.89% | -6.44% | -24.85% | 1,738.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 128.92% | -- | 346,900.00% | -- |
| Total Current Assets | 69.54% | -37.17% | 109.39% | 92.61% | 75.26% |
|
|
|||||
| Total Current Assets | 69.54% | -37.17% | 109.39% | 92.61% | 75.26% |
| Net Property, Plant & Equipment | 166.67% | 25.00% | -52.38% | -65.75% | -78.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 69.55% | -37.16% | 109.28% | 69.54% | 57.05% |
|
|
|||||
| Total Accounts Payable | 11.99% | -14.11% | 36.48% | -8.93% | 46.02% |
| Total Accrued Expenses | 212.65% | -- | 20.27% | -9.19% | -49.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 65.08% | 53.49% | -- | -- | -- |
| Total Other Current Liabilities | 65.08% | 53.49% | -- | -- | -- |
| Total Current Liabilities | 69.06% | 14.57% | 30.66% | -5.86% | -2.64% |
|
|
|||||
| Total Current Liabilities | 69.06% | 14.57% | 30.66% | -5.86% | -2.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 69.06% | 14.57% | 30.66% | -5.86% | -2.64% |
|
|
|||||
| Common Stock & APIC | 67.41% | 11.58% | 83.11% | 80.03% | 70.50% |
| Retained Earnings | -45.07% | -43.56% | -45.15% | -55.88% | -57.38% |
| Treasury Stock & Other | -4.35% | -24.52% | -7.19% | 7.71% | 23.35% |
| Total Common Equity | 69.58% | -41.09% | 123.11% | 79.95% | 63.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 69.58% | -41.09% | 123.11% | 79.95% | 63.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 69.58% | -41.09% | 123.11% | 79.95% | 63.55% |
|
|
|||||